Spago Nanomedical Future Growth
Future criteria checks 6/6
Spago Nanomedical is forecast to grow earnings and revenue by 56% and 50.6% per annum respectively. EPS is expected to grow by 62.3% per annum. Return on equity is forecast to be 128% in 3 years.
Key information
56.0%
Earnings growth rate
62.3%
EPS growth rate
| Biotechs earnings growth | 36.3% |
| Revenue growth rate | 50.6% |
| Future return on equity | 128.0% |
| Analyst coverage | Low |
| Last updated | 08 Feb 2024 |
Recent future growth updates
Recent updates
We're Not Worried About Spago Nanomedical's (STO:SPAGO) Cash Burn
Sep 21
We're Interested To See How Spago Nanomedical (STO:SPAGO) Uses Its Cash Hoard To Grow
May 26Loss-Making Spago Nanomedical AB (publ) (STO:SPAG) Set To Breakeven
Mar 30We're Hopeful That Spago Nanomedical (NGM:SPAG) Will Use Its Cash Wisely
Feb 03
Loss-Making Spago Nanomedical AB (publ) (NGM:SPAG) Expected To Breakeven In The Medium-Term
Dec 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 111 | 46 | 45 | 46 | 2 |
| 12/31/2025 | 14 | -51 | -51 | -51 | 1 |
| 12/31/2024 | 29 | -33 | -32 | -31 | 1 |
| 12/31/2023 | 6 | -42 | -45 | -45 | N/A |
| 9/30/2023 | 9 | -41 | -44 | -40 | N/A |
| 6/30/2023 | 9 | -42 | -50 | -45 | N/A |
| 3/31/2023 | 8 | -44 | -48 | -43 | N/A |
| 12/31/2022 | 6 | -39 | -42 | -38 | N/A |
| 9/30/2022 | 6 | -39 | -47 | -43 | N/A |
| 6/30/2022 | 6 | -41 | -47 | -43 | N/A |
| 3/31/2022 | 6 | -43 | -44 | -40 | N/A |
| 12/31/2021 | 6 | -39 | -40 | -36 | N/A |
| 9/30/2021 | 7 | -32 | -35 | -29 | N/A |
| 6/30/2021 | 7 | -27 | -29 | -23 | N/A |
| 3/31/2021 | 7 | -20 | -28 | -22 | N/A |
| 12/31/2020 | 7 | -19 | -25 | -19 | N/A |
| 9/30/2020 | 7 | -20 | -40 | -22 | N/A |
| 6/30/2020 | 13 | -21 | -33 | -21 | N/A |
| 3/31/2020 | 16 | -21 | -37 | -23 | N/A |
| 12/31/2019 | 19 | -20 | -40 | -21 | N/A |
| 9/30/2019 | 25 | -18 | -45 | -16 | N/A |
| 6/30/2019 | 25 | -15 | -40 | -16 | N/A |
| 3/31/2019 | 27 | -13 | -44 | -10 | N/A |
| 12/31/2018 | 30 | -11 | -39 | -11 | N/A |
| 9/30/2018 | 30 | -11 | -19 | -10 | N/A |
| 6/30/2018 | 27 | -10 | -34 | -7 | N/A |
| 3/31/2018 | 23 | -10 | -24 | -9 | N/A |
| 12/31/2017 | 18 | -9 | -26 | -8 | N/A |
| 9/30/2017 | 13 | -8 | N/A | -7 | N/A |
| 6/30/2017 | 12 | -8 | N/A | -7 | N/A |
| 3/31/2017 | 11 | -7 | N/A | -7 | N/A |
| 12/31/2016 | 11 | -8 | N/A | -8 | N/A |
| 9/30/2016 | 9 | -7 | N/A | -7 | N/A |
| 6/30/2016 | 8 | -7 | N/A | -6 | N/A |
| 3/31/2016 | 8 | -7 | N/A | -7 | N/A |
| 12/31/2015 | 8 | -7 | N/A | -5 | N/A |
| 9/30/2015 | 7 | -8 | N/A | -7 | N/A |
| 6/30/2015 | 7 | -7 | N/A | -8 | N/A |
| 3/31/2015 | 7 | -7 | N/A | -7 | N/A |
| 12/31/2014 | 8 | -6 | N/A | -6 | N/A |
| 9/30/2014 | 7 | -7 | N/A | -6 | N/A |
| 6/30/2014 | 9 | -7 | N/A | -5 | N/A |
| 3/31/2014 | 8 | -5 | N/A | -3 | N/A |
| 12/31/2013 | 8 | -5 | N/A | -8 | N/A |
| 9/30/2013 | 10 | -4 | N/A | -3 | N/A |
| 6/30/2013 | 9 | -4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SPAGO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: SPAGO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SPAGO is expected to become profitable in the next 3 years.
Revenue vs Market: SPAGO's revenue (50.6% per year) is forecast to grow faster than the Swedish market (2.4% per year).
High Growth Revenue: SPAGO's revenue (50.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SPAGO's Return on Equity is forecast to be very high in 3 years time (128%).